Clinical Trial Update: Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor [Phase 1, Phase 2]

View source ↗

Summary

A double-blind, placebo-controlled pilot study of octanoic acid in essential tremor (Phase 1/2) has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• Octanoic acid (octanoic acid)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Essential Tremor | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-12-27